Biotech · Private company

OncoMed Pharmaceuticals, Inc.

Track this companyFree. Adds OncoMed Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials250 recruiting or active

Pipeline programs43From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline43

Abraxane®Phase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Nonsquamous Nonsmall Cell Neoplasm of LungClinicalTrials.gov · fetched Nov 12, 2026
Cisplatin or CarboplatinPhase 2 · Stage IV Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
demcizumabPhase 2 · Nonsquamous Nonsmall Cell Neoplasm of LungClinicalTrials.gov · fetched Nov 12, 2026
DemcizumabPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
EtoposidePhase 2 · Stage IV Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
gemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
GemcitabinePhase 2 · Stage IV Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Nab-PaclitaxelPhase 2 · Stage IV Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-59R5Phase 2 · Stage IV Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-59R5Phase 2 · Stage IV Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 2 · Nonsquamous Nonsmall Cell Neoplasm of LungClinicalTrials.gov · fetched Nov 12, 2026
brontictuzumabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
DemcizumabPhase 1 · Primary Peritoneal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
DemcizumabPhase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
FOLFIRIPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
FOLFIRIPhase 1 · Advanced Relapsed TumorsClinicalTrials.gov · fetched Nov 12, 2026
FOLFOXPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Nab-PaclitaxelPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · Locally Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-131R10Phase 1 · Advanced Relapsed TumorsClinicalTrials.gov · fetched Nov 12, 2026
OMP-18R5Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
OMP-21M18Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
OMP-305B83Phase 1 · Advanced Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
OMP-305B83Phase 1 · Cancer OvariesClinicalTrials.gov · fetched Nov 12, 2026
OMP-305B83Phase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-313M32Phase 1 · Locally Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-336B11Phase 1 · Locally Advanced Malignant NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
OMP-52M51Phase 1 · Relapsed or Refractory Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
OMP-52M51Phase 1 · Relapsed or Refractory Lymphoid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
OMP-54F28Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
OMP-54F28 with SorafenibPhase 1 · Hepatocellular CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-54F28, Nab-Paclitaxel and GemcitabinePhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-54F28, Paclitaxel and CarboplatinPhase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
OMP-59R5Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 1 · Cancer OvariesClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
TaxolPhase 1 · Primary Peritoneal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
trifluridine/tipiracilPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
vantictumabPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
VantictumabPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Vantictumab combined with paclitaxelPhase 1 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic TumorsPHASE1 · TERMINATED · started Sep 12, 2017ClinicalTrials.gov NCT03295942 · fetched Nov 12, 2026
A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid TumorsPHASE1 · TERMINATED · started May 2, 2017ClinicalTrials.gov NCT03119428 · fetched Nov 12, 2026
A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal CancerPHASE1 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT03031691 · fetched Nov 12, 2026
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube CancerPHASE1 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03030287 · fetched Nov 12, 2026
A Study of OMP-305B83 in Subjects With Metastatic Colorectal CancerPHASE1 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT03035253 · fetched Nov 12, 2026
A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid TumorsPHASE1 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02722954 · fetched Nov 12, 2026
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10PHASE1 · COMPLETED · started Jul 16, 2015ClinicalTrials.gov NCT02482441 · fetched Nov 12, 2026
Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaPHASE2 · COMPLETED · started Apr 20, 2015ClinicalTrials.gov NCT02289898 · fetched Nov 12, 2026
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung CancerPHASE2 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02259582 · fetched Nov 12, 2026
A Phase 1 Study of OMP-305B83 in Subjects With Solid TumorsPHASE1 · COMPLETED · started Dec 22, 2014ClinicalTrials.gov NCT02298387 · fetched Nov 12, 2026
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian CancerPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02092363 · fetched Nov 12, 2026
Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular CancerPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02069145 · fetched Nov 12, 2026
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerPHASE1 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT02050178 · fetched Nov 12, 2026
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast CancerPHASE1 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01973309 · fetched Nov 12, 2026
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic CancerPHASE1 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT02005315 · fetched Nov 12, 2026
A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLCPHASE1 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01957007 · fetched Nov 12, 2026
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant OvarianPHASE1 · TERMINATED · started Aug 5, 2013ClinicalTrials.gov NCT01952249 · fetched Nov 12, 2026
A Dose Escalation Study of OMP-52M51 in Subjects With Solid TumorsPHASE1 · COMPLETED · started Feb 1, 2013ClinicalTrials.gov NCT01778439 · fetched Nov 12, 2026
A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid MalignanciesPHASE1 · COMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01703572 · fetched Nov 12, 2026
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic CancerPHASE1_PHASE2 · COMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01647828 · fetched Nov 12, 2026
A Dose Escalation Study of OMP-54F28 in Subjects With Solid TumorsPHASE1 · COMPLETED · started Jun 1, 2012ClinicalTrials.gov NCT01608867 · fetched Nov 12, 2026
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum TherapyPHASE1_PHASE2 · TERMINATED · started Jan 7, 2012ClinicalTrials.gov NCT01859741 · fetched Nov 12, 2026
A Dose Escalation Study of OMP-18R5 in Subjects With Solid TumorsPHASE1 · COMPLETED · started May 1, 2011ClinicalTrials.gov NCT01345201 · fetched Nov 12, 2026
A Dose Escalation Study of OMP-59R5 in Subjects With Solid TumorsPHASE1 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01277146 · fetched Nov 12, 2026
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid TumorsPHASE1 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00744562 · fetched Nov 12, 2026